Lemaitre Vascular is a medical device company focused on developing, manufacturing, and marketing innovative products for the treatment of vascular diseases
The company specializes in providing solutions for vascular surgeons, particularly in areas such as endovascular and open surgical procedures. Lemaitre Vascular offers a range of products, including synthetic grafts, stents, balloons, and devices used in the treatment of conditions such as peripheral artery disease and varicose veins. Through its commitment to research and development, the company aims to enhance patient outcomes and improve the effectiveness of vascular interventions.
Over the past six months, LeMaitre’s shares (currently trading at $83.18) have posted a disappointing 10.5% loss while the S&P 500 was down 4.1%. This may have investors wondering how to approach the situation.
Looking back on surgical equipment & consumables - specialty stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Integra LifeSciences (NASDAQ:IART) and its peers.
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the surgical equipment & consumables - specialty industry, including Intuitive Surgical (NASDAQ:ISRG) and its peers.
Medical device company LeMaitre Vascular (NASDAQ:LMAT) missed Wall Street’s revenue expectations in Q4 CY2024, but sales rose 14% year on year to $55.72 million. Next quarter’s revenue guidance of $57.7 million underwhelmed, coming in 1.6% below analysts’ estimates. Its GAAP profit of $0.49 per share was in line with analysts’ consensus estimates.
